25000 participants
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-09
- Start Date:
- 2025-10-22
- Completion:
- 2026-07-31
Conditions
- Respiratory Syncytial Virus (RSV)
Interventions
- BIOLOGICAL
No Results Yet